Exciting Insights from the 2025 International Limb Girdle Muscular Dystrophy Conference
The Speak Foundation is thrilled to announce the upcoming fourth International Limb Girdle Muscular Dystrophy (LGMD) Conference, taking place at the luxurious J.W. Marriott Orlando. This event, showcasing cutting-edge research and discussions on LGMD, aims to empower individuals affected by this condition.
What is the Focus of the Conference?
The International LGMD conference serves as a vibrant platform for patients, caregivers, healthcare professionals, researchers, and advocacy groups, emphasizing unity across all forms of LGMD. Attendees can expect to gain insights from top experts in the field, who will share the latest advancements in research and drug development.
Building a Community
This conference is primarily oriented towards the patient and advocacy community. It offers updates on diagnostics, medical management, natural history studies, and preclinical research aimed at exploring new treatment avenues. The patient experience is at the forefront, ensuring that all participants can walk away with valuable knowledge and connections.
Engaging Breakout Sessions
One of the highlights of the conference will be a series of engaging breakout sessions designed to cultivate community ties and promote advocacy efforts for LGMD. These sessions will feature expert clinicians sharing practical disease management tips alongside peers sharing personal experiences and strategies for living well with LGMD.
Recognition of Excellence in LGMD
During the conference, two distinguished experts will be celebrated with awards recognizing their Lifetime Achievement and Clinical Excellence in the field of LGMD. Notable confirmed speakers include acclaimed professionals like Dr. Volker Straub from the University of Newcastle and Dr. Louise Rodino-Klapac from Sarepta Therapeutics.
Voices that Inspire Change
Douglas Sproule, M.D., M.Sc., Chief Medical Officer of ML Bio Solutions, expresses pride in supporting the LGMD community. He emphasizes that gatherings like this one foster knowledge and empower individuals living with LGMD. Louise Rodino-Klapac echoes these sentiments, noting the inspiring growth of the LGMD community and the importance of ongoing learning and adaptation in treatment and care.
Support from Sponsors
Gratitude is extended towards the conference's platinum level sponsors, which include prominent organizations like Sarepta Therapeutics. This company is leading efforts in gene therapy treatments targeting various genetic subtypes of LGMD, while ML Bio Solutions focusses on developing targeted therapies for LGMD 2I/R9.
Registration Details
For those interested in attending, registration is now open. It is encouraged to register promptly as space is limited. This exciting opportunity comes with not only access to groundbreaking information but also the chance to forge lasting connections within the LGMD community.
About The Speak Foundation
The Speak Foundation is a dedicated nonprofit organization committed to supporting individuals affected by all forms of LGMD. Their mission is to facilitate the development of effective treatments to improve the quality of life for those living with this condition.
Understanding Limb-Girdle Muscular Dystrophy
Limb-Girdle Muscular Dystrophy (LGMD) encompasses a diverse group of muscular dystrophies resulting from mutations in multiple genes. The condition presents a spectrum of symptoms and progression, leading to significant disability and life-threatening health issues.
About ML Bio Solutions
ML Bio Solutions, part of BridgeBio, has been tirelessly dedicated to finding treatments for LGMD Type 2I/R9. Their research is oriented towards BBP-418, a novel oral treatment that could revolutionize care for patients affected by this subtype of LGMD.
About Sarepta Therapeutics
Sarepta Therapeutics is innovating at the frontier of genetic medicine, with a focus on rare diseases such as LGMD. Their extensive pipeline includes numerous programs aimed at addressing the complexities of muscular dystrophies, ensuring a future with better treatment options for affected individuals.
Frequently Asked Questions
What is the purpose of the International LGMD Conference?
The conference brings together patients, caregivers, researchers, and advocates to share knowledge on LGMD and discuss the latest advancements in treatment and research.
Who are some of the confirmed speakers at the conference?
Experts including Dr. Volker Straub and Dr. Louise Rodino-Klapac will be delivering talks at the conference.
What types of sessions will be available during the conference?
There will be breakout sessions focused on education, community connection, and disease management strategies for attendees.
Is there a registration fee for attending the conference?
Yes, registration is required and space is limited, so early registration is encouraged.
What support does The Speak Foundation provide?
The Speak Foundation supports individuals with LGMD and promotes research for effective treatments to enhance their quality of life.
